Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
I-Reconstruction Group Therapy for Anxiety
NCT07397429Recruiting
- Sponsor
- International Association of Psychosomatics and Health Therapy
- Start
- Mar 2026
- Primary completion
- May 2027
- Countries
- 1
01
Overview
Randomised, open-label trial in anxiety disorder and major depressive disorder (MDD) (3 arms), sponsored by International Association of Psychosomatics and Health Therapy. Primary endpoints: Beck Anxiety Inventory at 60 weeks, Hospital Anxiety and Depression Scale - Anxiety at 60 weeks and 1 more. Started Mar 2026; status: recruiting.
02
Conditions
anxiety disordermajor depressive disorder (MDD)
Beyond the preview
Go deeper on NCT07397429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07397429.